International Myeloma Foundation
MYELOMA MINUTE | Up To The Minute News | 12.10.2020
doctors and researchers in lab
imwg conference series ash 2020 banner
Watch a Replay of the Popular Livestream: the IMWG from ASH
The IMF’s International Myeloma Working Group, a collaborative body of some of the world’s top myeloma experts, convened at this year’s virtual 62nd American Society of Hematology (ASH) annual conference. The following doctors from the IMWG shared the latest news and trends of the treatment of myeloma from ASH: IMF Chairman of the Board Dr. Brian G.M. Durie (Cedars-Sinai Outpatient Cancer Center — Los Angeles), Dr. Thomas Martin (University of California at San Francisco — San Francisco), Dr. María V. Mateos (University of Salamanca — Salamanca, Spain), and IMF Chief Medical Officer Dr. Joseph Mikhael (TGen, City of Hope — Phoenix). Tune in now to a replay of this livestream.
2020WatchNowButton.png
support group leaders at ash
IMF Support Group Leaders Have Their Fingers on the Pulse of ASH 2020
In case you missed it, the IMF’s myeloma support group leaders and patients participated in the virtual 62nd annual meeting of the American Society of Hematology (ASH), an exciting convergence of 20,000 healthcare professionals from around the world. Visit the link below to read their informative blogs from the virtual event!
2020ReadNowButton.png
jeff wood novis award
Watch This Video of Myeloma Patient Jeff Wood Sharing His Story
In the following video, myeloma patient Jeff Wood shares how he lives well with myeloma. Diagnosed with the disease in July 2018, Jeff soon found the IMF Support Group network within six months. He also began attending IMF's Regional Community Workshops. During a normal year, patients share their stories in-person, as part of the Brian D. Novis Grant Awards Reception at the American Society of Hematology (ASH) annual conference. Because of the pandemic, Jeff was kind enough to tell his story online.
2020WatchNowButton.png
clinical-trials-paper.jpg
Phase II HORIZON Study in Multiple Myeloma Published in the Journal of Clinical Oncology
The peer-reviewed Journal of Clinical Oncology has published “the pivotal phase II HORIZON study evaluating intravenous melflufen (INN melphalan flufenamide) in combination with dexamethasone in relapsed refractory multiple myeloma.” Data from this study “are the basis for the ongoing priority review of the New Drug Application to the US Food and Drug Administration (FDA), for accelerated approval of melflufen in combination with dexamethasone in triple-class refractory multiple myeloma patients, who are refractory to at least one proteasome inhibitor, one immunomodulatory drug, and one anti-CD38 monoclonal antibody.”
2020LearnMoreButton.png
hawaii-beach.jpg
And This Too Shall Pass…
Once again, the IMF is hosting a raffle for a 10-day stay at the Villa Ono Oasis in historic Kailua-Kona, Hawaii. While many of us have been affected by COVID-19, we hope to remind you that this too shall pass. If you purchase the winning $50 raffle ticket, you could find yourself just minutes from the Hawaiian coastline. The winner will be announced on April 2, 2021. Note: Bookings will be in the future based on mutual availability with you and the property owner.
learn more
ask doctor durie video image
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
This Week’s Question:

COVID 19 FAQ #25: How can the “Swiss cheese” model help myeloma patients stay safe? 
Watch Now
 
Clinical Trials
OCEAN Trial (Fully Accrued)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)
Search the Myeloma Matrix 2.0

Smart Patients: Join the Conversation
Upcoming Events
Watch the Replay
“Living Well with Myeloma” Webinar

Watch the Replay
IMF Patient & Family Webinar

Learn More
Winter Challenge

Click here to see all events
 

We Thank Our Sponsors:

Amgen; Bristol-Myers Squibb; Genentech; GSK; Oncopeptides, Inc.; Sanofi-Genzyme; and Takeda Oncology
We also thank individuals like you for your continued support!
Subscribe Button@2x.jpg
2020ButtonDonateBurg.png
Join the conversation at The International Myeloma Foundation
Facebook Facebook: /Myeloma  |  Twitter Twitter @IMFMyeloma  |  Instagram Instagram @IMFmyeloma

www.myeloma.org
This email was sent by:
The International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
Connect with the IMF InfoLine
1-800-452-2873
We respect your privacy and your preferences for communications of this nature.
Home  •  Unsubscribe  •  Privacy Policy
View as web page